Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 6 studies | 68% ± 16% | |
astrocyte | 4 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 30224.38 | 226 / 226 | 99% | 201.32 | 401 / 406 |
prostate | 100% | 993.70 | 244 / 245 | 95% | 6.30 | 479 / 502 |
brain | 98% | 454.58 | 2587 / 2642 | 96% | 5.97 | 679 / 705 |
breast | 98% | 764.08 | 451 / 459 | 81% | 4.74 | 911 / 1118 |
lung | 97% | 992.69 | 563 / 578 | 77% | 12.33 | 889 / 1155 |
uterus | 100% | 898.01 | 170 / 170 | 71% | 3.89 | 324 / 459 |
thymus | 98% | 494.28 | 640 / 653 | 71% | 2.55 | 429 / 605 |
adrenal gland | 95% | 489.90 | 246 / 258 | 71% | 3.63 | 163 / 230 |
esophagus | 99% | 648.21 | 1426 / 1445 | 66% | 4.29 | 120 / 183 |
pancreas | 100% | 2405.14 | 328 / 328 | 63% | 2.59 | 112 / 178 |
kidney | 99% | 595.13 | 88 / 89 | 49% | 2.45 | 441 / 901 |
stomach | 100% | 1232.96 | 358 / 359 | 46% | 2.75 | 132 / 286 |
skin | 98% | 601.00 | 1772 / 1809 | 48% | 2.28 | 226 / 472 |
intestine | 97% | 667.33 | 941 / 966 | 44% | 2.40 | 233 / 527 |
bladder | 100% | 784.05 | 21 / 21 | 37% | 2.08 | 184 / 504 |
ovary | 100% | 861.41 | 180 / 180 | 21% | 0.83 | 91 / 430 |
blood vessel | 100% | 1093.71 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 761.42 | 1189 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 468.34 | 236 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 4.65 | 35 / 45 |
heart | 62% | 178.49 | 534 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 1.66 | 14 / 29 |
peripheral blood | 40% | 107.09 | 375 / 929 | 0% | 0 | 0 / 0 |
muscle | 16% | 32.09 | 126 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 14% | 0.38 | 11 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0006957 | Biological process | complement activation, alternative pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0006935 | Biological process | chemotaxis |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0006958 | Biological process | complement activation, classical pathway |
GO_0010760 | Biological process | negative regulation of macrophage chemotaxis |
GO_0010575 | Biological process | positive regulation of vascular endothelial growth factor production |
GO_0060326 | Biological process | cell chemotaxis |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005579 | Cellular component | membrane attack complex |
GO_0008009 | Molecular function | chemokine activity |
GO_0004866 | Molecular function | endopeptidase inhibitor activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | C5 |
Protein name | Complement C5 Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain] Complement component 5 |
Synonyms | CPAMD4 |
Description | FUNCTION: Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.; FUNCTION: [C5a anaphylatoxin]: Derived from proteolytic degradation of complement C5, C5a anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes . C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. . |
Accessions | U6BZC6 P01031 ENST00000697922.1 ENST00000466280.2 A0A8V8TN26 A0A8Q3SIH6 A0A8V8TMU5 ENST00000223642.3 A0A8Q3SID6 ENST00000696281.1 ENST00000696279.1 |